Eric A. Harwood

BACKGROUND

Eric Harwood is the Chair of Seed’s Chemistry and Biotechnology Group. His practice focuses on chemical, pharmaceutical, and life science patent prosecution, strategy, and diligence matters. Eric earned a B.S. in Chemistry from the University of California at Davis (summa cum laude), and M.S. and Ph.D. degrees in Organic Chemistry from the University of Washington in Seattle. He received a J.D. from the University of Washington School of Law, where he now serves as an Adjunct Professor.

EXPERIENCE

Eric advises clients in patent matters in a wide variety of chemical industries, including early-stage drug candidates and FDA-approved products, nanostructured composite materials, heterogeneous catalysts and electroplated materials. He has successfully prosecuted Orange Book listed patents and assists clients in licensing and acquisition matters valued in the hundreds of millions of dollars in the pharmaceutical, material science, and petrochemical industries. Eric especially enjoys understanding his client’s business objectives and then applying his expertise and experience in both patent law and chemistry to ensure those objectives are met. Prior to his career in law, Eric spent eight years working as both a medicinal and process chemist at small and multi-national pharmaceutical companies, where he designed and synthesized antibacterial, antiviral and kinase inhibitor drug candidates.

AFFILIATIONS

Eric is a member of the Washington State Bar and is registered to practice before the U.S. Patent and Trademark Office. He is a faculty member of the University of Washington School of Law where he teaches the Law School’s course on patent application preparation and prosecution. Eric is a member of the Washington State Patent Law Association, the American Chemical Society, and Life Science Washington. He volunteers for the local Juvenile Diabetes Research Foundation (JDRF), and is passionate about finding a cure and better treatments for those living with Type 1 diabetes.